Physician profile
Eric E Stone
NPI 1669511689
$1,564.89
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2021: $211 · 2022: $557 · 2023: $386 · 2024: $159 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $418.54 | 2019-2024 | |
| Abbvie INC. | $313.02 | 2021-2025 | Skyrizi, Rinvoq, Creon |
| Janssen Biotech, INC. | $136.83 | 2021-2025 | Tremfya |
| Enterra Medical, INC. | $135.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.47 | 2021-2023 | Entyvio, Gattex |
| Pfizer INC. | $108.04 | 2019-2024 | |
| Boston Scientific Corporation | $101.99 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $60.00 | 2021 | |
| Celltrion USA INC. | $31.54 | 2025 | Vegzelma |
| Regeneron Healthcare Solutions, INC. | $27.22 | 2022 | |
| Pharmacosmos Therapeutics INC. | $21.61 | 2024 | Monoferric |
| Gilead Sciences, INC. | $19.44 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.94 | 2023 | Rebyota |
| Glaxosmithkline, LLC. | $17.79 | 2021 | |
| Celgene Corporation | $17.22 | 2023 | Zeposia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.